Publications by authors named "Elisa Vigna"

Claim this Profile
C
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.
Raffaella De Maria, Chiara Donini, Sonia Capellero, Annamaria Massa, Federica Galvagno, Elisa Vigna

Cancer Immunol Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quasi-randomised pilot study on the efficacy and perceived usefulness of adding chemosignals to mindfulness practice for women with social anxiety.
Emma T Eliasson, Elisa Vigna, Elisa Dal Bò, Cinzia Cecchetto, Letizia Zurlo

Sci Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.
Raffaella De Maria, Chiara Donini, Sonia Capellero, Annamaria Massa, Federica Galvagno, Elisa Vigna

Cancer Immunol Immunother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sniffing out a solution: How emotional body odors can improve mindfulness therapy for social anxiety.
Cinzia Cecchetto, Elisa Dal Bò, Emma T Eliasson, Elisa Vigna, Ludovica Natali

J Affect Disord· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
Federica Galvagno, Valeria Leuci, Annamaria Massa, Chiara Donini, Ramona Rotolo, Elisa Vigna

Cancer Immunol Immunother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.
Marco Cortese, Erica Torchiaro, Alice D'Andrea, Consalvo Petti, Federica Invrea, Elisa Vigna

Mol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET Oncogene Targeting for Cancer Immunotherapy.
Andrea Maria Lombardi, Dario Sangiolo, Elisa Vigna

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supported employment, quality of jobs and employment typicalness: The experience of the Engage to Change project.
Elisa Vigna, Andrea Meek, Stephen Beyer

J Appl Res Intellect Disabil· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of COVID-19 pandemic on jobs for people with intellectual disabilities and autism in Wales.
Elisa Vigna, Andrea Meek, Stephen Beyer

J Appl Res Intellect Disabil· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, Ilenia Iaia, Chiara Donini, Elisa Vigna

J Exp Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A demographic and qualitative analysis of the determinants of success in a National Supported Employment project.
Elisa Vigna, Stephen Beyer, Andrea Meek

J Appl Res Intellect Disabil· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination.
Chiara Modica, Marco Cortese, Francesca Bersani, Andrea Maria Lombardi, Francesca Napoli, Elisa Vigna

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.
Ramona Rotolo, Valeria Leuci, Chiara Donini, Federica Galvagno, Annamaria Massa, Elisa Vigna

Clin Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
Cristina Chiriaco, Chiara Donini, Marco Cortese, Stefano Ughetto, Chiara Modica, Elisa Vigna

J Exp Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
Ilaria Martinelli, Chiara Modica, Cristina Chiriaco, Cristina Basilico, James M Hughes, Elisa Vigna

J Exp Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
Ilaria Martinelli, Chiara Modica, Cristina Chiriaco, Cristina Basilico, James M Hughes, Elisa Vigna

J Exp Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor.
Claudia Desole, Simona Gallo, Annapia Vitacolonna, Elisa Vigna, Cristina Basilico

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HGF/MET Axis Induces Tumor Secretion of Tenascin-C and Promotes Stromal Rewiring in Pancreatic Cancer.
Chiara Modica, Martina Olivero, Francesca Zuppini, Melissa Milan, Cristina Basilico, Elisa Vigna

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A receptor-antibody hybrid hampering MET-driven metastatic spread.
Chiara Modica, Cristina Basilico, Cristina Chiriaco, Nicla Borrelli, Paolo M Comoglio, Elisa Vigna

J Exp Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.
Valeria Leuci, Chiara Donini, Giovanni Grignani, Ramona Rotolo, Giulia Mesiano, Elisa Vigna

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody.
Chiara Modica, Simona Gallo, Cristina Chiriaco, Martina Spilinga, Paolo Maria Comoglio, Elisa Vigna

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
Valentina Martin, Cristina Chiriaco, Chiara Modica, Anna Acquadro, Marco Cortese, Elisa Vigna

Br J Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk.
Chiara Modica, Dora Tortarolo, Paolo M Comoglio, Cristina Basilico, Elisa Vigna

Int J Mol Sci· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-"decoy" strategy.
Cristina Basilico, Chiara Modica, Federica Maione, Elisa Vigna, Paolo M Comoglio

Int J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis